carbinoxamine maleate extended-release oral suspension
Generic: carbinoxamine maleate
Labeler: neos therapeutics, lpDrug Facts
Product Profile
Brand Name
carbinoxamine maleate extended-release oral suspension
Generic Name
carbinoxamine maleate
Labeler
neos therapeutics, lp
Dosage Form
SUSPENSION, EXTENDED RELEASE
Routes
Active Ingredients
carbinoxamine maleate 4 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
62542-101
Product ID
62542-101_3e88e362-ac97-23cc-e063-6294a90a4c1b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA022556
Listing Expiration
2026-12-31
Marketing Start
2024-06-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
62542101
Hyphenated Format
62542-101
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
carbinoxamine maleate extended-release oral suspension (source: ndc)
Generic Name
carbinoxamine maleate (source: ndc)
Application Number
NDA022556 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/5mL
Packaging
- 480 mL in 1 BOTTLE, PLASTIC (62542-101-05)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3e88e362-ac97-23cc-e063-6294a90a4c1b", "openfda": {"upc": ["0362542101059"], "unii": ["02O55696WH"], "rxcui": ["1374770"], "spl_set_id": ["199f46e5-6288-5627-e063-6294a90ae086"], "manufacturer_name": ["Neos Therapeutics, LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "480 mL in 1 BOTTLE, PLASTIC (62542-101-05)", "package_ndc": "62542-101-05", "marketing_start_date": "20240601"}], "brand_name": "Carbinoxamine Maleate Extended-Release Oral Suspension", "product_id": "62542-101_3e88e362-ac97-23cc-e063-6294a90a4c1b", "dosage_form": "SUSPENSION, EXTENDED RELEASE", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "62542-101", "generic_name": "Carbinoxamine Maleate", "labeler_name": "Neos Therapeutics, LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbinoxamine Maleate Extended-Release Oral Suspension", "active_ingredients": [{"name": "CARBINOXAMINE MALEATE", "strength": "4 mg/5mL"}], "application_number": "NDA022556", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20240601", "listing_expiration_date": "20261231"}